{"groups":[{"description":"Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) imaging: Patients will receive Ga-68 labeled PSMA-11 PET and then undergo PET/CT or PET/MRI approximately 55-70 minutes later.\n\nGa-68 labeled PSMA-11 PET: Patients will be imaged using Ga-68 labeled PSMA-11 PET to determine if the presence of metastatic disease. Prostate Specific Membrane Antigen (PSMA) is a protein expressed on prostate cancer cells that can be imaged using small molecules that target this protocol.","id":"FG000","title":"Ga-68 Labeled PSMA-11 Positron Emission Tomography (PET)"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"385"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"385"}],"type":"Investigational Drug Administration"},{"achievements":[{"groupId":"FG000","numSubjects":"385"}],"type":"PET/CT Scan"},{"achievements":[{"groupId":"FG000","numSubjects":"385"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}